Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platform Adaptive Embedded Trial for ARDS (PETARDS)
NCT05658692Phase 4Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Stem Cell Therapies, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, hydrocortisone, thymosin alpha 1, vecuronium, simvastatin in acute respiratory distress syndrome (ARDS), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
dexamethasonehydrocortisonethymosin alpha 1vecuroniumsimvastatin
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05658692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05658692.